The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

Artificial intelligence (AI) has emerged as a transformative force in the life sciences sector, driving significant advancements in research, patient care, and drug development. This blog explores the remarkable growth of AI in life sciences, highlighting key trends, future projections, and major factors contributing to this expansion.

Current Market Size and Growth

Exponential Growth in Recent Years

• Market Size in 2023: $2.35 billion
• Market Size in 2024: $2.92 billion
• Compound Annual Growth Rate (CAGR): 24.2%

The recent surge in market size can be attributed to:

• Clinical Trials: Increasing number of trials leveraging AI for efficiency and accuracy.
• Research and Development: Widespread adoption of AI in R&D activities.
• Precision Medicine: High emphasis on developing personalized drugs and treatments.

Future Market Projections

Sustained Exponential Growth

• Market Size in 2028: $6.82 billion
• CAGR: 23.6%

Key drivers for future growth include:

• Remote Patient Monitoring (RPM): Growing interest in real-time RPM systems.
• Drug Discovery: Increasing demand for AI-driven drug discovery processes.
• Medical Imaging Analysis: Rising adoption of AI in analyzing medical images.

Read More On The Artificial Intelligence In Life Sciences Market Report 2024 – https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-life-sciences-global-market-report

Trends and Innovations

Strategic Partnerships and Product Innovations

• Collaborations: Increasing number of strategic partnerships in AI and life sciences.
• Technological Advancements: Continuous innovation in AI technologies and applications.
• Investments: Significant investments in AI research and development.

Surge in Remote Patient Monitoring

The rising interest in RPM systems is significantly boosting AI adoption in life sciences:

• RPM Systems: Technology-driven solutions for monitoring patients outside traditional settings.
• AI Integration: Providing continuous, personalized, and data-driven healthcare insights.
• Survey Insights: According to Livelink, clinicians’ use of RPM grew by 305% from 2021 to 2022.

Technological Advancements

Major companies are focusing on innovative AI products to maintain market leadership:

• Drug Discovery Software: Advanced AI tools assisting in drug discovery.
• Example: Merck’s AIDDISON software, launched in December 2023, integrates generative AI, machine learning, and computer-aided drug design to identify non-toxic and soluble drug candidates.

Strategic Acquisitions

Varix Acquires Start-Up.ai

• Acquisition Date: June 2023
• Objective: Strengthening AI and machine learning capabilities for pharma commercial operations.
• Impact: Enhancing Varix’s AI-driven commercial optimization platform.

Major Players in the Market

Leading companies driving innovation in AI for life sciences include:

• Google LLC
• Microsoft Corporation
• Intel Corporation
• IBM Corporation
• Medtronic PLC
• Nvidia Corporation
• Novo Nordisk A/S
• Siemens Healthineers AG
• Philips Healthcare

Market Segmentation

By Offering

• Software
• Hardware
• Services

By Deployment

• On-Premises
• Cloud-Based

By Application

• Drug Discovery
• Medical Diagnosis
• Biotechnology
• Clinical Trials
• Precision and Personalized Medicine
• Patient Monitoring

Regional Insights

• North America: Largest market in 2023.
• Asia-Pacific: Expected to be the fastest-growing region in the forecast period.

Conclusion

The artificial intelligence in life sciences market is poised for continued exponential growth, driven by advancements in technology, increasing demand for AI applications in healthcare, and strategic industry partnerships. As AI continues to revolutionize the life sciences sector, it will play a crucial role in enhancing patient care, accelerating drug discovery, and advancing personalized medicine.

Request for A Sample Of The Global Artificial Intelligence In Life Sciences Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=13587&type=smp